TABLE 2.

Overall Impact of Risk group–specific Disruptions: Relative Increase in New HIV Infections and HIV-Related Deaths overall Over 1 year Due to: A) Cessation of New ART Initiations and 50% Reduction in the Proportion of Virally Suppressed Among Those on ART in all and Specific Risk Groups and B) 50% Reduction in all Condom Use in all and Specific Partnerships (Impact on HIV Incidence Only)

	% HIV-Related Deaths		% New HIV Infections
	Yaoundé	Cotonou	Yaoundé	Cotonou
A)
Affected risk group
All	15.7% (11.2–19.0)	22.4% (11.8–46.9)	21.4% (18.3–26.0)	19.0% (10.5–32.7)
FSW and clients	1.7% (0.9–2.7)	3.3% (1.5–7.9)	5.5% (3.0–8.5)	10.3% (5.3–17.6)
Non-FSW and non-clients	13.7% (10.0–17.5)	19.5% (9.4–39.2)	16.2% (12.5–20.1)	9.0% (4.9–15.9)
FSW	0.7% (0.3–1.6)	0.3% (0.2–0.5)	2.3% (0.8–4.4)	3.8% (1.9–6.3)
Clients	1.0% (0.4–1.6)	3.1% (1.3–7.6)	3.2% (1.5–5.0)	6.0% (2.7–12.5)
MSM	1.1% (0.4–1.6)	NA	5.5% (2.1–8.5)	NA
FSW, clients, and MSM	2.9% (1.7–3.9)	NA	11.1% (6.5–14.6)	NA
Non-FSW, non-clients, and non-MSM	12.6% (8.8–16.6)	NA	11.1% (6.7–15.3)	NA
B)
Affected partnerships
All			22.6% (14.6–31.1)	23.1% (12.3–48.6)
FSW and clients with all partners			8.5% (4.8–13.7)	21.4% (11.4–46.8)
Between FSW and clients			4.5% (2.0–9.3)	18.5% (8.9–42.0)
Non-FSW and non-clients with all partners			17.3% (11.2–25.2)	4.2% (2.6–6.3)
Between non-FSW and nonclients			14.2% (7.7–21.1)	1.5% (0.8–2.6)
MSM with all partners			10.6% (4.7–17.9)	NA
FSW with all partners			5.9% (2.6–10.8)	18.5% (8.9–42.0)
Clients with all partners			7.0% (4.0–12.2)	21.4% (11.4–46.8)
MSM, FSW, and clients with all partners			18.9% (13.1–28.4)	NA
Between MSM, FSW, and clients			10.9% (6.3–17.0)	NA
Non-MSM, non-FSW, and non-clients with all partners			10.3% (6.4–16.0)	NA
Between non-MSM, non-FSW, and non-clients			3.5% (1.4–6.9)	NA

NA, not available as not modeled in Cotonou.